NorthRock Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
4,147
-369
| -8% | -$150K | 0.04% | 153 |
|
|
2025
Q1 | $2.25M | Buy |
4,516
+60
| +1% | +$29.9K | 0.08% | 110 |
|
|
2024
Q4 | $2.32M | Sell |
4,456
-1,615
| -27% | -$841K | 0.08% | 106 |
|
|
2024
Q3 | $3.76M | Buy |
6,071
+1,163
| +24% | +$720K | 0.12% | 82 |
|
|
2024
Q2 | $2.72M | Buy |
4,908
+702
| +17% | +$388K | 0.1% | 95 |
|
|
2024
Q1 | $2.45M | Buy |
4,206
+533
| +15% | +$310K | 0.09% | 106 |
|
|
2023
Q4 | $1.95M | Buy |
3,673
+928
| +34% | +$493K | 0.08% | 115 |
|
|
2023
Q3 | $1.39M | Buy |
2,745
+131
| +5% | +$66.3K | 0.15% | 74 |
|
|
2023
Q2 | $1.36M | Sell |
2,614
-66
| -2% | -$34.4K | 0.15% | 66 |
|
|
2023
Q1 | $1.54M | Buy |
2,680
+27
| +1% | +$15.6K | 0.16% | 60 |
|
|
2022
Q4 | $1.46M | Sell |
2,653
-1,267
| -32% | -$698K | 0.17% | 67 |
|
|
2022
Q3 | $1.99M | Sell |
3,920
-104
| -3% | -$52.7K | 0.23% | 45 |
|
|
2022
Q2 | $2.19M | Buy |
4,024
+2,276
| +130% | +$1.24M | 0.23% | 45 |
|
|
2022
Q1 | $1.03M | Sell |
1,748
-455
| -21% | -$269K | 0.09% | 99 |
|
|
2021
Q4 | $1.47M | Buy |
2,203
+848
| +63% | +$566K | 0.11% | 75 |
|
|
2021
Q3 | $817K | Sell |
1,355
-70
| -5% | -$42.2K | 0.07% | 106 |
|
|
2021
Q2 | $719K | Buy |
1,425
+152
| +12% | +$76.7K | 0.06% | 107 |
|
|
2021
Q1 | $581K | Buy |
1,273
+42
| +3% | +$19.2K | 0.05% | 113 |
|
|
2020
Q4 | $573K | Buy |
1,231
+497
| +68% | +$231K | 0.06% | 119 |
|
|
2020
Q3 | $324K | Buy |
+734
| New | +$324K | 0.04% | 154 |
|